Influence of Pulmonary Hypertension on Survival in Advanced Lung Disease
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Background Effects of pulmonary hypertension (PH) in advanced lung disease remain unclear.Methods The United Network for Organ Sharing database was queried from 1987 to 2013 to assess survival lung transplant candidates to determine influence of PH in advanced lung disease. Thresholds included mean pulmonary artery pressure ≥ 25 mmHg (mild PH) and 35 mmHg (severe PH).Results Of 12,405 listed possible candidates, 10,158 were used for univariate analysis, 7050 for Kaplan-Meier (KM) function, 6196 for multivariate Cox models, and 5328 (mild PH) and 1910 (severe PH) for propensity score matching (PSM). For mild and severe PH, univariate revealed that PH was associated with survival difference (HR = 1.530, 95% CI 1.416, 1.654, p < 0.001) and (HR = 2.033, 95% CI 1.851, 2.232, p < 0.001), respectively. KM function curves demonstrated a significant difference for mild PH (Log-rank test: Chi square (df = 1): 117.76, p < 0.0001) and severe PH (Log-rank test: Chi square (df = 1): 230.91, p < 0.0001). Multivariate Cox models also found a significant increased risk for death for mild PH (HR = 1.750, 95% CI 1.606, 1.907, p < 0.001) and severe PH (HR = 2.088, 95% CI 1.879, 2.319, p < 0.001). PSM confirmed this increased risk for death for mild PH (HR = 1.695, 95% CI 1.502, 1.914, p < 0.001) and severe PH (HR = 1.976, 95% CI 1.641, 2.379, p < 0.001).Conclusions PH is associated with significant increased risk for death in patients with advanced lung disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The OPTN/UNOS registry data demonstrate that Group 3 pulmonary hypertension is common in patients with advanced CF, ILD, and COPD and is associated with increased oxygen requirements and increased mortality.(294–299)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [299]
Citations
Cites
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Updated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Clinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Echocardiographic Assessment of Pulmonary Hypertension in Patients with Advanced Lung Disease
Arcasoy, S. M., Christie, J. D., Ferrari, V. A., Sutton, M. S. J., Zisman, D. A., Blumenthal, N. P., Pochettino, A., & Kotloff, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1130oc · Cited by 906
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Lettieri, C. J., Nathan, S. D., Barnett, S. D., Ahmad, S., & Shorr, A. F. (2006) · Chest · doi:10.1378/chest.129.3.746 · Cited by 879
Severe Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Chaouat, A., Bugnet, A.-S., Kadaoui, N., Schott, R., Enache, I., Ducoloné, A., Ehrhart, M., Kessler, R., & Weitzenblum, E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-006oc · Cited by 714
WAGENVOORT, C. A., & WAGENVOORT, N. (1970) · Circulation · doi:10.1161/01.cir.42.6.1163 · Cited by 562
Thabut, G., Dauriat, G., Stern, J. B., Logeart, D., Levy, A., Marrash-Chahla, R., & Mal, H. (2005) · Chest · doi:10.1378/chest.127.5.1531 · Cited by 494
Idiopathic Pulmonary Fibrosis and Emphysema
Mejía, M., Carrillo, G., Rojas-Serrano, J., Estrada, A., Suárez, T., Alonso, D., Barrientos, E., Gaxiola, M., Navarro, C., & Selman, M. (2009) · Chest · doi:10.1378/chest.08-2306 · Cited by 468
Pulmonary Hypertension in Patients With Idiopathic Pulmonary Fibrosis
Nadrous, H. F., Pellikka, P. A., Krowka, M. J., Swanson, K. L., Chaowalit, N., Decker, P. A., & Ryu, J. H. (2005) · Chest · doi:10.1378/chest.128.4.2393 · Cited by 427
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
Shorr, A. F., Wainright, J. L., Cors, C. S., Lettieri, C. J., & Nathan, S. D. (2007) · European Respiratory Journal · doi:10.1183/09031936.00107206 · Cited by 377
Stage IV sarcoidosis: comparison of survival with the general population and causes of death
Nardi, A., Brillet, P.-Y., Letoumelin, P., Girard, F., Brauner, M., Uzunhan, Y., Naccache, J.-M., Valeyre, D., & Nunes, H. (2011) · European Respiratory Journal · doi:10.1183/09031936.00187410 · Cited by 272
The Influence of Hydrogen Ion Concentration and Hypoxia on the Pulmonary Circulation*
Enson, Y., Giuntini, C., Lewis, M. L., Morris, T. Q., Ferrer, M. I., & Harvey, R. M. (1964) · Journal of Clinical Investigation · doi:10.1172/jci104999 · Cited by 268
Andersen, K. H., Iversen, M., Kjaergaard, J., Mortensen, J., Nielsen-Kudsk, J. E., Bendstrup, E., Videbaek, R., & Carlsen, J. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2011.11.020 · Cited by 267
Nathan, S. D., Shlobin, O. A., Barnett, S. D., Saggar, R., Belperio, J. A., Ross, D. J., Ahmad, S., Saggar, R., Libre, E., Lynch, J. P., et al. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.03.022 · Cited by 238
Survival in Sarcoidosis-Associated Pulmonary Hypertension
Baughman, R. P., Engel, P. J., Taylor, L., & Lower, E. E. (2010) · Chest · doi:10.1378/chest.09-2002 · Cited by 234
Kimura, M., Taniguchi, H., Kondoh, Y., Kimura, T., Kataoka, K., Nishiyama, O., Aso, H., Sakamoto, K., & Hasegawa, Y. (2013) · Respiration · doi:10.1159/000345221 · Cited by 222
Pulmonary Diseases and the Heart
Han, M. K., McLaughlin, V. V., Criner, G. J., & Martinez, F. J. (2007) · Circulation · doi:10.1161/circulationaha.106.685206 · Cited by 215
Echocardiographic and Hemodynamic Predictors of Mortality in Idiopathic Pulmonary Fibrosis
Rivera‐Lebron, B. N., Forfia, P. R., Kreider, M. E., Lee, J. C., Holmes, J. H., & Kawut, S. M. (2013) · CHEST Journal · doi:10.1378/chest.12-2298 · Cited by 120
CLINICAL CLASSIFICATION OF PULMONARY HYPERTERNSION
Fishman, A. P. (2001) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70278-1 · Cited by 119
Wrobel, J. P., Thompson, B. R., & Williams, T. J. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.02.029 · Cited by 112
Pulmonary hypertension in interstitial lung disease: Prevalence, prognosis and 6 min walk test
Andersen, C. U., Mellemkjær, S., Hilberg, O., Nielsen‐Kudsk, J. E., Simonsen, U., & Bendstrup, E. M. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.02.015 · Cited by 104
Abnormalities of Sodium and H2O Handling in Chronic Obstructive Lung Disease
Farber, M. O. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.1982.00340200086019 · Cited by 96
Carlsen, J., Andersen, K. H., Boesgaard, S., Iversen, M., Steinbrüchel, D. A., & Andersen, C. B. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.11.014 · Cited by 95
Fluid homeostasis in chronic obstructive lung disease
de Leeuw, P. W., & Dees, A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00000603a · Cited by 80
Pulmonary hypertension in cystic fibrosis with advanced lung disease
Hayes, D., Tobias, J. D., Mansour, H. M., Kirkby, S., McCoy, K. S., Daniels, C. J., & Whitson, B. A. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201407-1382oc · Cited by 77
Self-citationSevere Pulmonary Hypertension in COPD
Weitzenblum, E., & Chaouat, A. (2005) · CHEST Journal · doi:10.1378/chest.127.5.1480 · Cited by 63
Mechanisms coupling the absorption of solutes and water in the proximal nephron
Schafer, J. A. (1984) · Kidney International · doi:10.1038/ki.1984.78 · Cited by 60
Prevalence of pulmonary hypertension in end-stage cystic fibrosis and correlation with survival
Tonelli, A. R., Fernández-Bussy, S., Lodhi, S., Akindipe, O., Carrie, R. D., Hamilton, K. K., Mubarak, K. K., & Baz, M. A. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.04.006 · Cited by 50
Papakosta, D., Pitsiou, G., Daniil, Z. D., Dimadi, M., Stagaki, E., Rapti, A., Antoniou, K. M., Τzouvelekis, Α., Kontakiotis, T., Τryfon, S., et al. (2011) · Lung · doi:10.1007/s00408-011-9304-5 · Cited by 44
Diagnostic and prognostic role of biomarkers for pulmonary hypertension in interstitial lung disease
Andersen, C. U., Mellemkjær, S., Nielsen‐Kudsk, J. E., Bendstrup, E. M., Simonsen, U., & Hilberg, O. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.09.003 · Cited by 43
Rapti, A., Kouranos, V., GIALAFOS, E. J., Aggeli, K. D., Moyssakis, J., Kallianos, A., Kostopoulos, C., Anagnostopoulou, O., Sfikakis, P. P., Wells, A. U., et al. (2012) · Lung · doi:10.1007/s00408-012-9442-4 · Cited by 42
Discontinuation of Furosemide Decreases Paco2 in Patients With COPD
Brijker, F., Heijdra, Y. F., van den Elshout, F. J. J., & Folgering, H. T. M. (2002) · CHEST Journal · doi:10.1378/chest.121.2.377 · Cited by 39
Hayes, D., Higgins, R. S., Kirkby, S., McCoy, K. S., Wehr, A. M., Lehman, A. M., & Whitson, B. A. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2013.12.004 · Cited by 35
Self-citationVenuta, F., Tonelli, A. R., Anile, M., Diso, D., Giacomo, T. D., Ruberto, F., Russo, E., Rolla, M., Quattrucci, S., Rendina, E. A., et al. (2012) · PubMed · Cited by 31
Pulmonary hypertension is a mild comorbidity in end-stage cystic fibrosis patients
Meerkerk, G. B., Cramer, M. J., Erp, J. M. K., Nugroho, M. A., Tahri, S., de Valk, H. W., & van de Graaf, E. A. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.03.006 · Cited by 28
Effects of Hypoxia and Hypercapnia on the Repartition of Pulmonary Blood Flow in Supine Subjects1
Durand, J., Ladurie, M. L. R., & Ranson-Bitker, B. (2015) · Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research · doi:10.1159/000391552 · Cited by 16
Right heart catheterization measuring central hemodynamics in cystic fibrosis during exercise
Hayes, D., Daniels, C. J., Mansour, H. M., Kopp, B. T., Yates, A. R., McCoy, K., Patel, A. V., & Kirkby, S. E. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.02.020 · Cited by 9
Self-citationPulmonary Hypertension in Parenchymal Lung Disease
Tsangaris, I., Tsaknis, G., Anthi, A., & Orfanos, S. E. (2012) · Pulmonary Medicine · doi:10.1155/2012/684781 · Cited by 6
Cited by
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
Bax, S., Bredy, C., Kempny, A., Dimopoulos, K., Devaraj, A., Walsh, S. L. F., Jacob, J., Nair, A., Kokosi, M. A., Keir, G. J., et al. (2018) · ERJ Open Research · doi:10.1183/23120541.00124-2017 · Cited by 40
Single lung transplantation in patients with severe secondary pulmonary hypertension
Nasir, B., Mulvihill, M. S., Barac, Y. D., Bishawi, M. M., Cox, M. L., Megna, D. J., Haney, J. C., Klapper, J. A., Daneshmand, M. A., & Hartwig, M. G. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.06.014 · Cited by 32
Acosta, M. F., Abrahamson, M. D., Encinas-Basurto, D., Fineman, J. R., Black, S. M., & Mansour, H. M. (2020) · The AAPS Journal · doi:10.1208/s12248-020-00531-3 · Cited by 32
Self-citationAcosta, M. F., Muralidharan, P., Grijalva, C. L., Abrahamson, M. D., Hayes, D., Fineman, J. R., Black, S. M., & Mansour, H. M. (2021) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466621998245 · Cited by 19
Self-citation
Metadata
- Authors
- Hayes, D., Black, S. M., Tobias, J. D., Mansour, H. M., & Whitson, B. A.
- Affiliations
- The Ohio State University (US)
- Nationwide Children's Hospital (US)
- University of Arizona (US)
- Corresponding author
- Hayes, Don
- Venue
- Lung
- Published
- 2015-02-18
- Volume
- 193
- Issue
- 2
- Pages
- 213-221
- ISSN
- 0341-2040 (ISSN-L)
- 1432-1750
- OpenAlex
- W2029308763
- Cited by
- 14
- References
- 40
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 1 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 3 · 2016: 1
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Lung (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Neonatal Respiratory Health Research
- Keywords
- pulmonary hypertension, advanced lung disease, lung transplant candidates, survival, mortality risk, mean pulmonary artery pressure
- MeSH terms
- Adult, Female, Humans, Hypertension, Pulmonary, Lung Diseases, Male, Middle Aged, Retrospective Studies, Severity of Illness Index, United States, Survival Rate, Proportional Hazards Models, Risk Assessment, Kaplan-Meier Estimate, Propensity Score
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.